{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T08:49:30Z","timestamp":1789202970670,"version":"build-2803163510"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T00:00:00Z","timestamp":1756166400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T00:00:00Z","timestamp":1756166400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Reprod. Sci."],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1007\/s43032-025-01960-1","type":"journal-article","created":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T16:48:08Z","timestamp":1756226888000},"page":"3336-3342","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Treatment Outcomes and Resistance Patterns in Low Risk GTN: A 270-Patient Experience from a Tertiary Center"],"prefix":"10.1007","volume":"32","author":[{"given":"Elham","family":"Shirali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fariba","family":"Yarandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Ramhormozian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-8878-9400","authenticated-orcid":false,"given":"Atena","family":"Abedini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,26]]},"reference":[{"key":"1960_CR1","unstructured":"Creasman WT, Mannel RS, Mutch DG, Tewari K. DiSaia and Creasman clinical gynecologic oncology. Philadelphia, PA: Elsevier Health Sciences. 2022."},{"issue":"2","key":"1960_CR2","doi-asserted-by":"publisher","first-page":"28","DOI":"10.5306\/wjco.v10.i2.28","volume":"10","author":"A Braga","year":"2019","unstructured":"Braga A, Mora P, de Melo AC, Nogueira-Rodrigues A, Amim-Junior J, Rezende-Filho J, et al. Challenges in the diagnosis and treatment of gestational trophoblastic neoplasia worldwide. World J Clin Oncol. 2019;10(2):28.","journal-title":"World J Clin Oncol"},{"issue":"6","key":"1960_CR3","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1046\/j.1471-0528.2003.01413.x","volume":"110","author":"B Tham","year":"2003","unstructured":"Tham B, Everard J, Tidy J, Drew D, Hancock B. Gestational trophoblastic disease in the Asian population of Northern England and North Wales. BJOG: An International Journal of Obstetrics & Gynaecology. 2003;110(6):555\u20139.","journal-title":"BJOG: An International Journal of Obstetrics & Gynaecology"},{"issue":"6","key":"1960_CR4","doi-asserted-by":"publisher","first-page":"e72","DOI":"10.3802\/jgo.2022.33.e72","volume":"33","author":"E Yamamoto","year":"2022","unstructured":"Yamamoto E, Nishino K, Niimi K, Ino K. Epidemiologic study on gestational trophoblastic diseases in Japan. J Gynecol Oncol. 2022;33(6): e72.","journal-title":"J Gynecol Oncol"},{"issue":"3","key":"1960_CR5","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/S0020-7292(02)00063-2","volume":"77","author":"FIGO Oncology Committee","year":"2002","unstructured":"FIGO Oncology Committee. FIGO staging for gestational trophoblastic neoplasia 2000. Int J Gynaecol Obstet. 2002;77(3):285\u20137.","journal-title":"Int J Gynaecol Obstet"},{"issue":"S1","key":"1960_CR6","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1002\/ijgo.13877","volume":"155","author":"HY Ngan","year":"2021","unstructured":"Ngan HY, Seckl MJ, Berkowitz RS, Xiang Y, Golfier F, Sekharan PK, et al. Diagnosis and management of gestational trophoblastic disease: 2021 update. Int J Gynaecol Obstet. 2021;155(S1):86\u201393.","journal-title":"Int J Gynaecol Obstet"},{"issue":"4","key":"1960_CR7","doi-asserted-by":"publisher","first-page":"e36","DOI":"10.3802\/jgo.2020.31.e36","volume":"31","author":"X Wu","year":"2020","unstructured":"Wu X, Qin J, Shen T, Fei W, Chen L, Xie X, et al. The 16-year experience in treating low-risk gestational trophoblastic neoplasia patients with failed primary methotrexate chemotherapy. J Gynecol Oncol. 2020;31(4): e36.","journal-title":"J Gynecol Oncol"},{"issue":"11","key":"1960_CR8","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1038\/bjc.2012.462","volume":"107","author":"A Sita-Lumsden","year":"2012","unstructured":"Sita-Lumsden A, Short D, Lindsay I, Sebire N, Adjogatse D, Seckl M, et al. Treatment outcomes for 618 women with gestational trophoblastic tumours following a molar pregnancy at the Charing Cross Hospital, 2000\u20132009. Br J Cancer. 2012;107(11):1810\u20134.","journal-title":"Br J Cancer"},{"key":"1960_CR9","doi-asserted-by":"crossref","unstructured":"Alazzam Mi, Tidy J, Osborne R, Coleman R, Hancock BW, Lawrie TA. Chemotherapy for resistant or recurrent gestational trophoblastic neoplasia. Cochrane Database Syst Rev. 2016;(1).","DOI":"10.1002\/14651858.CD008891.pub3"},{"key":"1960_CR10","doi-asserted-by":"crossref","unstructured":"Branco-Silva M, Maest\u00e1 I, Horowitz N, Elias K, Seckl M, Berkowitz R. Recurrence and resistance risk factors in low-risk gestational trophoblastic neoplasia. Int J Gynecol Cancer. 2025;101876.","DOI":"10.1136\/ijgc-2024-005770"},{"key":"1960_CR11","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.ejca.2020.02.011","volume":"130","author":"C Lok","year":"2020","unstructured":"Lok C, van Trommel N, Massuger L, Golfier F, Seckl M, Abreu MH, et al. Practical clinical guidelines of the EOTTD for treatment and referral of gestational trophoblastic disease. Eur J Cancer. 2020;130:228\u201340.","journal-title":"Eur J Cancer"},{"issue":"3","key":"1960_CR12","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.ygyno.2012.03.039","volume":"125","author":"E Chapman-Davis","year":"2012","unstructured":"Chapman-Davis E, Hoekstra AV, Rademaker AW, Schink JC, Lurain JR. Treatment of nonmetastatic and metastatic low-risk gestational trophoblastic neoplasia: factors associated with resistance to single-agent methotrexate chemotherapy. Gynecol Oncol. 2012;125(3):572\u20135.","journal-title":"Gynecol Oncol"},{"issue":"7","key":"1960_CR13","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1200\/JCO.2010.30.4386","volume":"29","author":"RJ Osborne","year":"2011","unstructured":"Osborne RJ, Filiaci V, Schink JC, Mannel RS, Alvarez Secord A, Kelley JL, et al. Phase III trial of weekly methotrexate or pulsed dactinomycin for low-risk gestational trophoblastic neoplasia: a gynecologic oncology group study. J Clin Oncol. 2011;29(7):825\u201331.","journal-title":"J Clin Oncol"},{"key":"1960_CR14","unstructured":"Akhavan S, Gilani MM, Mousavi A, Hasani SS, Nokhostin F. Is not it the time to change the treatment of intermediate-risk patients suffering from gestational trophoblastic neoplasia? Pain. 2020;50(18.14)."},{"issue":"1","key":"1960_CR15","first-page":"47","volume":"14","author":"S Sheikhhasani","year":"2023","unstructured":"Sheikhhasani S, Abdolrazaghnejad A, Mousavi AS, Akhavan S, Zamani N, Feizabad E. Resistance to single-agent chemotherapy in low-risk gestational trophoblastic neoplasia. Casp J Intern Med. 2023;14(1):47.","journal-title":"Casp J Intern Med"},{"issue":"15","key":"1960_CR16","doi-asserted-by":"publisher","first-page":"3184","DOI":"10.1016\/j.ejca.2013.06.004","volume":"49","author":"F Taylor","year":"2013","unstructured":"Taylor F, Grew T, Everard J, Ellis L, Winter M, Tidy J, et al. The outcome of patients with low risk gestational trophoblastic neoplasia treated with single agent intramuscular methotrexate and oral folinic acid. Eur J Cancer. 2013;49(15):3184\u201390.","journal-title":"Eur J Cancer"},{"issue":"3","key":"1960_CR17","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.62347\/ZUCG8140","volume":"14","author":"T Jin","year":"2024","unstructured":"Jin T, Zhou Z, Lin M, Yuan S, Xue Y, Yin T, et al. Risk factors for methotrexate resistance in low-risk gestational trophoblastic neoplasia patients (FIGO score 0\u20134). Am J Cancer Res. 2024;14(3):1353.","journal-title":"Am J Cancer Res"},{"key":"1960_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12885-021-08849-7","volume":"21","author":"J Hao","year":"2021","unstructured":"Hao J, Zhou W, Zhang M, Yu H, Zhang T, An R, et al. Direct comparisons of efficacy and safety between actinomycin-D and methotrexate in women with low-risk gestational trophoblastic neoplasia: a meta-analysis of randomized and high-quality non-randomized studies. BMC Cancer. 2021;21:1\u201314.","journal-title":"BMC Cancer"},{"issue":"8","key":"1960_CR19","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1093\/annonc\/mdx211","volume":"28","author":"Y Eysbouts","year":"2017","unstructured":"Eysbouts Y, Ottevanger P, Massuger L, IntHout J, Short D, Harvey R, et al. Can the FIGO 2000 scoring system for gestational trophoblastic neoplasia be simplified? A new retrospective analysis from a nationwide dataset. Ann Oncol. 2017;28(8):1856\u201361.","journal-title":"Ann Oncol"},{"issue":"3","key":"1960_CR20","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1631\/jzus.B2100895","volume":"23","author":"Y Weng","year":"2022","unstructured":"Weng Y, Liu Y, Benjoed C, Wu X, Tang S, Li X, et al. Evaluation and simplification of risk factors in FIGO 2000 scoring system for gestational trophoblastic neoplasia: a 19-year retrospective analysis. Journal of Zhejiang University-SCIENCE B. 2022;23(3):218\u201329.","journal-title":"Journal of Zhejiang University-SCIENCE B"},{"key":"1960_CR21","doi-asserted-by":"crossref","unstructured":"Frijstein M, Lok C, van Trommel N, Ten Kate\u2010Booij M, Massuger L, van Werkhoven E, et al. Lung metastases in low\u2010risk gestational trophoblastic neoplasia: a retrospective cohort study. BJOG: An Int J Obstet Gynaecol. 2020;127(3):389\u201395.","DOI":"10.1111\/1471-0528.16036"},{"key":"1960_CR22","doi-asserted-by":"crossref","unstructured":"Farazestanian M, Hamidi B, Hasanzademofrad M, HomaeiShandiz F, Davachi B, Yousefi Z, et al. Study of low-risk GTN patients resistant to first-line chemotherapy with MTX in a tertiary hospital center. J Obstet Gynecol Cancer Res. 2025.","DOI":"10.24200\/jogcr.10.10.747"},{"issue":"12","key":"1960_CR23","doi-asserted-by":"publisher","first-page":"3720","DOI":"10.1200\/JCO.1998.16.12.3720","volume":"16","author":"H Joensuu","year":"1998","unstructured":"Joensuu H, Holli K, Heikkinen M, Suonio E, Aro AR, Hietanen P, et al. Combination chemotherapy versus single-agent therapy as first-and second-line treatment in metastatic breast cancer: a prospective randomized trial. J Clin Oncol. 1998;16(12):3720\u201330.","journal-title":"J Clin Oncol"},{"key":"1960_CR24","doi-asserted-by":"publisher","first-page":"1035170","DOI":"10.3389\/fonc.2022.1035170","volume":"12","author":"L Kemin","year":"2022","unstructured":"Kemin L, Mengpei Z, Rutie Y. Monotherapy for low-risk gestational trophoblastic neoplasia with score 5\u20136. Front Oncol. 2022;12: 1035170.","journal-title":"Front Oncol"}],"container-title":["Reproductive Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43032-025-01960-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s43032-025-01960-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43032-025-01960-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T17:41:46Z","timestamp":1761154906000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s43032-025-01960-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,26]]},"references-count":24,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["1960"],"URL":"https:\/\/doi.org\/10.1007\/s43032-025-01960-1","relation":{},"ISSN":["1933-7191","1933-7205"],"issn-type":[{"value":"1933-7191","type":"print"},{"value":"1933-7205","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,26]]},"assertion":[{"value":"6 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest"}}]}}